Back to results
US 2003/0190354 A1Published application
Extended release composition comprising as active compound venlafaxine hydrochloride
OwnerYoram Selainventor
Life of this patent
Estimating the term…
Abstract
A composition suitable for use in making extended release tablets of venlafaxine hydrochloride is described.
Claims16
An extended release composition comprising as active compound venlafaxine hydrochloride in a matrix tablet dosage form, in which the venlafaxine is mixed with a combination of hydrophilic and hydrophobic matrix forming components.
Controlled release tablet dosage form having a unique combination of hydrophilic and hydrophobic matrix forming components which allows the controlled release of the extremely water soluble drug venlafaxine hcl, and also enables the production of tablets in an acceptable size and with acceptable physical characteristics.
Dependencies are inferred from the claim text.